Remove 2021 Remove Compounding Remove Vaccines
article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

Vaccines 108
article thumbnail

$3 trillion growth reported for biotech sector

European Pharmaceutical Review

trillion dollars in 2021. The report also found that in 2021, the US industry employed 2.1 trillion dollars in 2021. For instance, small and mid-sized biotech companies invested heavily in developing vaccines. To date, 747 novel compounds are in production. million people in over 127,000 businesses.

Vaccines 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Rapid microbiology testing market growth expected 2022 to 2027

European Pharmaceutical Review

A report has predicted the rapid microbiology testing market size is estimated to grow at a compound annual growth rate (CAGR) of 9.31 The research includes historic market data from 2017 to 2021, using 2022 as the base year. million in 2017 and continued to grow until 2021. percent between 2022 and 2027.

article thumbnail

Preventing fungal contamination in pharmaceuticals

European Pharmaceutical Review

In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. One case of drug contamination from 2021 was highlighted in the paper. Ahmed et al. Ahmed et al.

article thumbnail

Dr B raises $8m for telehealth service to deliver COVID antivirals

pharmaphorum

US startup Dr B – formed in 2021 to help match patients seeking a COVID-19 vaccine to suppliers with leftover stock – is branching out into antivirals with the help of an $8 million fundraising. Take up of both antiviral treatments is reported to be highest in the US, with 2.5

article thumbnail

2022 in review: Drug development milestones for tropical diseases

Pharmaceutical Technology

Novel therapeutics and vaccines for malaria. The same report estimates that there were 247 million malaria cases in 2021 across 84 endemic countries. In the same month, GSK’s malaria vaccine Mosquirix received prequalification from the WHO, bringing it closer to a rollout in children.

Vaccines 105
article thumbnail

As resistant tuberculosis rises, GSK says trial backs novel antibiotic

pharmaphorum

Cases of drug-resistant TB (DR-TB) rose 3% in 2021 over the previous year, the first increase since record-keeping started in 2004, according to the WHO report, which called for countries to move quickly to restore access to essential services to treat the disease, as well as greater investment in new vaccines and therapeutics.